Login / Signup

Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.

Anna CandoniDavide LazzarottoCristina PapayannidisMatteo PicciniGiampaolo NadaliMichelina DargenioMarta RivaNicola FracchiollaLorella MellilloGiulia DragonettiMaria Ilaria Del PrincipeChiara CattaneoManuela StulleCrescenza PasciollaRoberta De MarchiMario DeliaMaria Chiara TisiValentina BonuomoAlessandra IurloAntonio SpadeaChiara SartorDavide GriguoloElisa BuzzattiClaudia Maria BasilicoChiara SarloAnna Lina PiccioniElisa CerquiFederica LessiAttilio OlivieriRenato FaninMario LuppiLivio Pagano
Published in: American journal of hematology (2023)
Keyphrases
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • risk factors
  • chronic lymphocytic leukemia
  • mesenchymal stem cells
  • cell therapy